OpenVSafe by OpenVAERS
Search V-safe

XG7-29517-26027

4 vaccinations 5 coded responses 24 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
040 / ME
Registered
2020-12-18
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Nausea
    Adult check-in
  9. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: COVID-19 — Feeling: Fair · Headache, Muscle or body aches · Be unable to work
    Free text: Positive for COVID 19
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-24
  11. 2020-12-25
    Survey response — day 7, dose 1
    MedDRA: COVID-19 — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Positive for COVID-19
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2020-12-25
    Report sent to call center — day 7, dose 1
    Be unable to work
    1 call case(s)
  13. 2021-01-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  15. 2021-01-15
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-05
    Survey response — day 28, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: New runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-10-11
    Dose 3 — Pfizer-BioNTech
  24. 2022-01-08
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2022-09-13
    Dose 4 — Pfizer-BioNTech
  26. 2022-10-04
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  27. 2022-10-11
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-10-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-10-25
    Survey response — day 42, dose 4
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: Cold
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-12-13
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  31. 2023-03-14
    Survey response — 6 months, dose 4
    MedDRA: Pregnancy — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech
32021-10-11Pfizer-BioNTech No
42022-09-13Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2020-12-24 priority 2/3
2020-12-25 priority 2/3

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-24

Systemic reaction (other): Positive for COVID 19

Release 1 — day 7, dose 1

2020-12-25

Systemic reaction (other): Positive for COVID-19

Release 3 — day 28, dose 2

2021-02-05

Symptoms: New runny nose

Release 12 — day 42, dose 4

2022-10-25

Symptoms: Cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDPregnancy · · ✓
SDRhinorrhoea ✓ ✓ ✓
SROCOVID-19 ✓ ✓ ✓
SROSARS-CoV-2 test positive ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release